Class I recall: Baxter Healthcare Corporation: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusi

The FDA has classified as Class I a recall by Baxter Healthcare Corporation of Cefazolin in Dextrose Injection, USP, 2g/100mL (20mg/mL), a frozen premix single-dose infusion bag distributed in the GALAXY plastic container (NDC 0338-3508-41). The recall was initiated due to the presence of particulate matter in the product. A Class I designation indicates the FDA's most serious recall category, reserved for situations in which use of the product may cause serious adverse health consequences or death.

Most relevant for: patients receiving intravenous cefazolin antibiotic therapy from affected Baxter Healthcare single-dose infusion bags

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.